SAN FRANCISCO (KGO) -- Basically everyone wants to see a treatment available for the novel coronavirus. Yes, both chloroquine and hydroxychloroquine are being looked at for their potential, but in ...

The anti-malaria drug that President Donald Trump has touted as a potential treatment for COVID-19 is already in shortage after demand skyrocketed in recent weeks, according to Business Insider.

It was touted as a watershed, a game-changer, a model and a transformational moment for the development of disease-fighting, health-improving vaccines. Five years later, however, the legacy of the ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Let's stay with the pandemic and the ...